Bio-Rad Laboratories Stock Price and Value Analysis

Should you buy Bio-Rad Laboratories stock? (NYSE:BIO). Let's see how it does in our automated value investing analysis system.

  • This company has fluctuating growth.
  • This company is less known than others.
  • This stock looks overpriced.
  • This company is not making money.
  • This company pays no dividend.

Inside the BIO Numbers

BIO Price
(Bio-Rad Laboratories stock price per share)
[?] PE Ratio versus Sector 224% higher than other Healthcare stocks
[?] PE Ratio versus Industry 67% lower than other Medical Laboratories & Research stocks
[?] Cash Yield 0.98%
[?] Free Cash Flow Jitter 30%

Is Bio-Rad Laboratories Stock on Sale?

Based on our analysis, we believe that you should not buy Bio-Rad Laboratories right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy BIO Stock?

Does Bio-Rad Laboratories have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.